White House to phase out virus task force
Administration to shift focus to economy
WASHINGTON — Despite growing evidence that the pandemic is still raging, administration officials said Tuesday that they had made so much progress in bringing it under control that they planned to wind down the coronavirus task force in the coming weeks and focus the White House on restarting the economy.
Vice President Mike Pence, who has led the task force for two months, said it would probably wrap up its work around the end of the May and shift management of the public health response back to the federal agencies whose work it was created to coordinate.
Other administration officials said that under plans still in discussion, the White House would consult with medical experts on a more informal basis and that Jared Kushner, the president’s sonin-law and senior adviser, would help oversee a group pushing for progress in developing a vaccine and treatments for the virus.
“It really is all a reflection of the tremendous progress we’ve made as a country,” Pence told reporters at the White House.
His comments came a day after the revelation of new estimates that suggest deaths from the coronavirus, now above 70,000, could double by early August and that infection rates may rise sharply as businesses reopen.
With President Donald Trump
facing a tough reelection battle, the White House appears intent on putting a response to the daily death toll more toward the background as it emphasizes efforts at a return to economic and job growth. The president’s advisers have repeatedly tried to place the responsibility for testing and decisions about reopening on individual states.
The task force spent some of its time preparing talking points for Trump, who took over its public briefings, often turning them into lengthy opportunities to air grievances, praise his own handling of the crisis and offer up his own prescriptions.
There were signals in recent days of the task force’s impending demise: The panel did not meet Saturday, as it typically does, and canceled a meeting Monday. And Trump has stopped linking his news briefings to the task force’s meetings and no longer routinely arrays task force members around him in his public appearances, a change that came swiftly after the president mused one day about the possibility of injecting disinfectants to kill the virus.
Members of the coronavirus task force, including Dr. Deborah Birx, the White House’s coronavirus response coordinator, had to urge Americans not to take those steps. And they often served as a public check on Trump’s questionable or false statements, cautioning about promises of a quick vaccine or the effectiveness of hydroxychloroquine, a drug promoted by the president.
While the task force’s advice has sometimes been swept aside by Trump and the guidelines it produced for states to reopen ignored by some of them, the group was a comforting symbol for people scared about the virus’s spread and looking for a sign the White House was taking it seriously. People closely monitored which members attended, noting any time Dr. Anthony Fauci, a leading infection disease expert, was absent. The decision to phase out the task force has prompted new questions about whether the administration will be adequately organized to address the complex, life-or-death decisions related to the virus and give sufficient voice to scientists and public health experts in making policy.
“We will have something in a different form,” Trump told reporters Tuesday during a trip to Arizona.
Asked why now was the right time to wind down the task force, Trump replied, “Because we can’t keep our country closed for the next five years.”
If there is a recurrence in the fall, he said, “we’re going to put the flame out.”
White House officials said that medical officials like Birx would still be advising the president and be available to answer reporters’ questions.
Still, the change means a growing role for Kushner, who is looking for a czarlike appointee to oversee the development of a vaccine and therapeutic treatments, as well as for top economic officials like Treasury Secretary Steven Mnuchin and White House advisers Larry Kudlow and Kevin Hassett.
Since it was formed in January, the task force has been the scene of bureaucratic and policy battling, its influence only as great as Trump’s episodic willingness to accept its advice.
“The task force has been hampered by inconsistent messaging,” said Dr. Joshua M. Sharfstein, a former top Food and Drug Administration official who teaches on public health crises at the Johns Hopkins Bloomberg School of Public Health. “There were too many times when what the scientists said and what the president said were at odds.”